Brucellosis is an infectious disease involving many organs and tissues. We investigated retrospectively the brucellosis cases at our hospital, in order to study the relationship between clinical, laboratory and therapy findings, and relapse rates. We found that relapse was related to a positive family history, living in a rural area and the presence of complications.
Get full access to this article
View all access options for this article.
References
1.
YoungEJ. Brucella species. In: MandellGL, BennettJE, DolinR, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th edn.New York: Churchill Livingstone, 2005;2669–74
2.
SoleraJ, GeijoP, LargoJ, A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human Brucellosis. Clin Infect Dis2004;39:1776–82
PappasG, AkritidisN, BosilkovskiM, TsianosE. Brucellosis. N Engl J Med2005;352:2325–36
5.
AkovaM, UzunO, AkalinEH, HayranM, UnalS, GurD. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother1993;37:1831–4
6.
ArizaJ, BosilkovskiM, CascioA, ColmeneroJD, CorbelMJ, FalagasME. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med2007;4:e317
7.
ArizaJ, CorredoiraJ, PallaresR, Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis1995;20:1241–9
8.
ColmeneroJD, RegueraJM, MartosF, Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine1996;75:195–211
9.
BosilkovskiM, KrtevaL, DimzovaM, KondovaI. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis2007;11:342–7
10.
RoushanMR, GangiSM, AhmadiSA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly2004;134:564–8
